characterisation of haematopoietic stem and progenitor cells in products intended for transplantation

Clicks: 56
ID: 248306
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #199 of 231 articles by views in planta medica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 231 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Haematopoietic stem and progenitor cells have been successfully used for autologous and al- logeneic transplantations for many years. Quantitative and qualitative laboratory assays allow controlling di erent cellular products during collection, concentration and preservation. The in- formation about cell number, viability, functionality and purity of the gra ensure safe applica- tion and help predict the likelihood of successful engra ment. Almost 50 years of research have disclosed the great heterogeneity of cells that exhibit a haematopoietic di erentiation potential. This will enable the identification of subpopulations within the population of CD34-positive ha- ematopoietic stem cells.
Reference Key
maliev2018zdravnikicharacterisation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Elvira Maličev;Metka Krašna
Journal planta medica
Year 2018
DOI
10.6016/ZdravVestn.1602
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.